Biometric Screening and Future Employer Medical Costs: Is It Worth It to Know?

J Occup Environ Med. 2017 Dec;59(12):1202-1210. doi: 10.1097/JOM.0000000000001188.

Abstract

Objective: To study the relationship between a biometric wellness data and future/actual medical costs.

Methods: A relationship between total cholesterol to high density lipoprotein ratio, blood pressure, and blood glucose and medical costs, based on analysis of claims data, was explored in 1834 employees that had both wellness program biometric and claims data in 2016.

Result: Increased total cholesterol to HDL ratio is strongly associated with increased average costs (P < 0.01). Similarly, an increased glucose level is strongly associated with increased average costs (P = 0.001). There was no evidence of a relationship between elevated blood pressure and higher costs.

Conclusions: By investing in an employer-sponsored biometric screening of full cholesterol and glucose profiles, medium-sized employers can identify high-risk employees who are expected to incur significantly higher healthcare costs, as compared with low-risk level employees, and improve treatment outcomes.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biometry / methods*
  • Blood Glucose
  • Blood Pressure
  • Employer Health Costs / statistics & numerical data*
  • Female
  • Health Care Costs / statistics & numerical data*
  • Health Promotion / economics
  • Humans
  • Linear Models
  • Lipids / blood
  • Male
  • Mass Screening / economics*
  • Mass Screening / methods
  • Middle Aged
  • Occupational Health Services / economics*
  • Young Adult

Substances

  • Blood Glucose
  • Lipids